Physician profile
Elham Mesri
NPI 1033387030
$1,389.30
in general payments reported to CMS, 2019-2025
11 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $383 · 2023: $66.70 · 2024: $231 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $403.55 | 2024-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $253.71 | 2021-2022 | |
| Lilly USA, LLC | $238.94 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Dexcom, INC. | $99.63 | 2022 | |
| Amgen INC. | $90.86 | 2024-2025 | Repatha, Repatha, Tepezza |
| Cranial Technologies, INC | $89.60 | 2022-2025 | Doc Band |
| Lucid Diagnostics INC. | $89.52 | 2022 | |
| Novartis Pharmaceuticals Corporation | $61.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.06 | 2024 | |
| Pfizer INC. | $20.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elham Mesri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.